Anxiety Disorders Completed Phase Trials for Gabapentin (DB00996)

Also known as: Anxiety Disorder / Anxiety NOS

IndicationStatusPhase
DBCOND0027904 (Anxiety Disorders)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00022074Gabapentin For the Control of Hot Flashes in Women With Breast CancerSupportive Care